Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Oct 5;18:261. doi: 10.1186/s12886-018-0929-5

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s). 2018

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

PMC Copyright notice

Fig. 1 — Our stepwise therapeutic approach for the patients with Behcet’s uveitis and distribution of the cases. *First Line Therapy: AZA: azathioprine, CS: corticosteroid, CsA: cyclosporine A, IFNα2a: interferon alpha2a, MTX: methotrexate. ^† except one case. **Second Line Therapy: Interferon alpha2a. ***Third Line Therapy: ADA: adalimumab, Anti-TNF-α: Anti tumor necrosis factor alpha, INX: infliximab. ****Fourth Line Therapy: this line is used if necessary